IN.TO
InMed Pharmaceuticals Inc
Price:  
4.19 
CAD
Volume:  
15,950.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IN.TO Relative Valuation

-475.9%
Upside

As of 2025-07-07, the Relative Valuation of InMed Pharmaceuticals Inc (IN.TO) is (15.75) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 CAD, the upside of InMed Pharmaceuticals Inc based on Relative Valuation is -475.9%.

The range of the Relative Valuation is (15.34) - (18.84) CAD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 7.2x - 13.8x 9.0x
Forward P/E multiples 11.2x - 17.8x 14.0x
Fair Price (15.34) - (18.84) (15.75)
Upside -466.1% - -549.7% -475.9%
4.19 CAD
Stock Price
(15.75) CAD
Fair Price

IN.TO Relative Valuation - Historical P/E Data

Date P/E